DHI GROUP, INC., 10-Q filed on 11/12/2024
Quarterly Report
v3.24.3
DOCUMENT AND ENTITY INFORMATION - shares
 9 Months Ended
Sep. 30, 2024
Nov. 08, 2024
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2024  
Entity Registrant Name DHI Group, Inc.  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding   48,332,278
Entity File Number 001-33584  
Entity Tax Identification Number 20-3179218  
Entity Address, Address Line One 6465 South Greenwood Plaza  
Entity Address, City or Town Centennial  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80111  
Local Phone Number 448-6605  
Trading Symbol DHX  
Entity Interactive Data Current Yes  
Security Exchange Name NYSE  
City Area Code 212  
Entity Central Index Key 0001393883  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Address, Address Line Two Suite 400  
Entity Incorporation, State or Country Code DE  
Title of 12(b) Security Common Stock, par value $0.01 per share  
v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash $ 2,073 $ 4,206
Accounts receivable, net of allowance for doubtful accounts of $1,288 and $1,313 19,653 22,225
Income Taxes Receivable 317 221
Prepaid and other current assets 3,964 4,237
Total current assets 26,007 30,889
Fixed assets, net 21,896 25,272
Acquired intangible assets, net 23,800 23,800
Capitalized contract costs 7,078 6,364
Goodwill 128,100 128,100
Operating lease right-of-use-assets (as reported) 6,810 4,759
Other assets 3,776 4,100
Equity Method Investments 1,926 1,918
Total assets 219,393 225,202
Current liabilities    
Accounts payable and accrued expenses 14,662 17,408
Operating lease liabilities - current 1,857 2,006
Deferred revenue 46,113 49,463
Total current liabilities 62,632 68,877
Long-term debt, net 32,000 38,000
Deferred Revenue, Noncurrent 800 508
Accrual for unrecognized tax benefits 1,206 1,032
Deferred Tax Liabilities, Tax Deferred Income 1,864 2,214
Operating lease liabilities - non-current (as reported) 9,170 6,543
Other long-term liabilities 409 486
Total liabilities $ 108,081 $ 117,660
Preferred Stock, Shares Issued 0 0
Stockholders equity    
Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding $ 0 $ 0
Common stock, $.01 par value, authorized 240,000; issued: 80,966 and 78,764 shares, respectively; outstanding: 48,341 and 46,875 shares, respectively 811 789
Additional paid-in capital 268,066 261,824
Accumulated other comprehensive loss 0 (83)
Accumulated earnings 31,459 32,228
Treasury stock, 32,625 and 31,889 shares, respectively (189,024) (187,216)
Total stockholders' equity 111,312 107,542
Total liabilities and stockholders’ equity $ 219,393 $ 225,202
v3.24.3
CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Preferred Stock, Shares Authorized 20,000,000 20,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Current assets    
Allowance for doubtful accounts $ 1,288 $ 1,313
Stockholders equity    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 240,000,000 240,000,000
Common stock, shares issued 80,966,000 78,764,000
Common stock, shares outstanding 48,341,000 46,875,000
v3.24.3
Statement of Income (Statement) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 35,283 $ 37,433 $ 107,141 $ 114,591
Operating expenses:        
Cost of revenue 5,068 4,971 15,145 14,839
Product development 4,776 4,432 14,303 13,284
Sales and marketing 11,585 14,036 36,302 44,819
General and administrative 7,574 7,210 22,097 23,871
Depreciation on continuing operations 4,542 4,241 13,584 12,576
Restructuring Costs 1,111 302 1,111 2,417
Total operating expenses 34,656 35,192 102,542 111,806
Operating income 627 2,241 4,599 2,785
Interest expense and other 755 939 2,546 2,616
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 23 153 325 428
Debt and Equity Securities, Unrealized Gain (Loss) 0 614 0 614
Gain (Loss) on Investments 0 (300) (400) (300)
Income (loss) before income taxes (105) 1,769 1,978 911
Income tax expense (benefit) 95 759 2,747 (432)
Net income (loss) $ (200) $ 1,010 $ (769) $ 1,343
Basic earnings (loss) per share (in dollars per share) $ 0 $ 0.02 $ (0.02) $ 0.03
Diluted earnings (loss) per share (in dollars per share) $ 0 $ 0.02 $ (0.02) $ 0.03
Weighted average basic shares outstanding 44,873 43,405 44,550 43,582
Weighted average diluted shares outstanding 44,873 44,324 44,550 44,579
v3.24.3
Consolidated Statements of Comprehensive Income (Loss) Statement - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ (200) $ 1,010 $ (769) $ 1,343
Foreign currency translation adjustment 30 55 83 211
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax 0 200 0 200
Total other comprehensive income 30 255 83 411
Comprehensive income (loss) $ (170) $ 1,265 $ (686) $ 1,754
v3.24.3
CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY Statement - USD ($)
$ in Thousands
Total
Restricted Stock
Performance Stock Units
Common Stock [Member]
Common Stock [Member]
Restricted Stock
Common Stock [Member]
Performance Stock Units
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Restricted Stock
Additional Paid-in Capital [Member]
Performance Stock Units
Accumulated Earnings (Loss) [Member]
Accumulated Other Comprehensive Loss [Member]
Treasury Stock, Common
Treasury Stock, Common
Restricted Stock
Treasury Stock, Common
Performance Stock Units
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares                       29,075,000    
Beginning balance (in shares) at Dec. 31, 2022       76,442,000                    
Beginning balance at Dec. 31, 2022 $ 106,239     $ 766     $ 251,632     $ 28,405 $ (481) $ (174,083)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 460                 460        
Other comprehensive income (loss) 150                   150      
Stock based compensation 2,887           2,887              
Restricted stock issued (in shares)       (1,107,000)                    
Restricted stock issued 0     $ (11)     (11)              
Forfeited (in shares)       (1,288,000)                    
Shares Granted, Value, Share-based Payment Arrangement, Forfeited 0     $ (13)     13              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (4,000) 0             (386,000) (512,000)
Share-based payment arrangement, decrease for tax withholding obligation   $ (2,278) $ (3,017)   $ 0 $ 0   $ 0 $ 0       $ (2,278) $ (3,017)
Accelerated Share Repurchase Program, Adjustment 3,521                     $ 3,521    
Stock Repurchased During Period, Shares                       743,000    
Ending balance (in shares) at Mar. 31, 2023       78,833,000                    
Ending balance at Mar. 31, 2023 101,252     $ 790     254,495     29,197 (331) $ (182,899)    
Beginning balance (in shares) at Dec. 31, 2022       76,442,000                    
Beginning balance at Dec. 31, 2022 $ 106,239     $ 766     251,632     28,405 (481) (174,083)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued during period, shares, employee stock purchase plans (in shares) 45,374                          
Stock Repurchased During Period, Shares 1,661,278,000                          
Ending balance (in shares) at Sep. 30, 2023       78,569,000                    
Ending balance at Sep. 30, 2023 $ 103,088     $ 787     259,481     30,080 (70) $ (187,190)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Cumulative-effect of new accounting principle 332                 332        
Treasury Stock, Common, Shares                       30,716,000    
Beginning balance (in shares) at Mar. 31, 2023       78,833,000                    
Beginning balance at Mar. 31, 2023 101,252     $ 790     254,495     29,197 (331) $ (182,899)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income (127)                 (127)        
Other comprehensive income (loss) 6                   6      
Stock based compensation 2,667           2,667              
Restricted stock issued (in shares)       (176,000)                    
Restricted stock issued 0     $ (2)     (2)              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (183,000) (110,000)             (26,000) 0
Share-based payment arrangement, decrease for tax withholding obligation   (95) 0   $ (2) $ (1)   2 1       $ (95) $ 0
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition (148)               148          
Stock issued during period, shares, employee stock purchase plans (in shares)           45,000                
Accelerated Share Repurchase Program, Adjustment 3,375                     $ 3,375    
Stock Repurchased During Period, Shares                       919,000    
Stock Issued During Period, Value, Employee Stock Purchase Plan           $ 0                
Ending balance (in shares) at Jun. 30, 2023       78,761,000                    
Ending balance at Jun. 30, 2023 100,476     $ 789     257,311     29,070 (325) $ (186,369)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares                       31,661,000    
Net income 1,010                 1,010        
Other comprehensive income (loss) 55                   55      
Stock based compensation 2,168           2,168              
Restricted stock issued (in shares)       (307,000)                    
Restricted stock issued 0     $ (3)     (3)              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (289,000) (210,000)             (135,000) (84,000)
Share-based payment arrangement, decrease for tax withholding obligation   (501) (320)   $ (3) $ (2)   3 2       $ (501) $ (320)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax $ 200                   200      
Stock Repurchased During Period, Shares 0                          
Ending balance (in shares) at Sep. 30, 2023       78,569,000                    
Ending balance at Sep. 30, 2023 $ 103,088     $ 787     259,481     30,080 (70) $ (187,190)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares                       31,880,000    
Treasury Stock, Common, Shares 31,889,000                     31,889,000    
Beginning balance (in shares) at Dec. 31, 2023 46,875,000     78,764,000                    
Beginning balance at Dec. 31, 2023 $ 107,542     $ 789     261,824     32,228 (83) $ (187,216)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income (1,512)                 (1,512)        
Other comprehensive income (loss) 22                   22      
Stock based compensation 2,144           2,144              
Restricted stock issued (in shares)       (1,344,000)                    
Restricted stock issued 0     $ (13)     (13)              
Forfeited (in shares)       (457,000)                    
Shares Granted, Value, Share-based Payment Arrangement, Forfeited 0     $ (5)     5              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (1,000) 0             (304,000) (342,000)
Share-based payment arrangement, decrease for tax withholding obligation   (750) (861)   $ 0 $ 0   0 0       $ (750) $ (861)
Ending balance (in shares) at Mar. 31, 2024       80,564,000                    
Ending balance at Mar. 31, 2024 $ 106,585     $ 807     263,950     30,716 (61) (188,827)    
Beginning balance (in shares) at Dec. 31, 2023 46,875,000     78,764,000                    
Beginning balance at Dec. 31, 2023 $ 107,542     $ 789     261,824     32,228 (83) (187,216)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued during period, shares, employee stock purchase plans (in shares) 81,874                          
Stock Repurchased During Period, Shares 0                          
Ending balance (in shares) at Sep. 30, 2024 48,341,000     80,966,000                    
Ending balance at Sep. 30, 2024 $ 111,312     $ 811     268,066     31,459 0 $ (189,024)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares                       32,535,000    
Beginning balance (in shares) at Mar. 31, 2024       80,564,000                    
Beginning balance at Mar. 31, 2024 106,585     $ 807     263,950     30,716 (61) $ (188,827)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 943                 943        
Other comprehensive income (loss) 31                   31      
Stock based compensation 2,160           2,160              
Restricted stock issued (in shares)       (318,000)                    
Restricted stock issued 0     $ (3)     (3)              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (54,000) (8,000)             (15,000) (4,000)
Share-based payment arrangement, decrease for tax withholding obligation   (34) (8)   $ (1) $ 0   1 0       $ (34) $ (8)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition (146)               145          
Stock issued during period, shares, employee stock purchase plans (in shares)           82,000                
Stock Issued During Period, Value, Employee Stock Purchase Plan           $ 1                
Ending balance (in shares) at Jun. 30, 2024       80,902,000                    
Ending balance at Jun. 30, 2024 109,823     $ 810     266,253     31,659 (30) $ (188,869)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares                       32,554,000    
Net income (200)                 (200)        
Other comprehensive income (loss) 30                   30      
Stock based compensation 1,814           1,814              
Restricted stock issued (in shares)       (196,000)                    
Restricted stock issued $ 0     $ (2)     (2)              
Shares forfeited or withheld to satisfy tax obligations (in shares)         (122,000) (10,000)             (71,000) 0
Share-based payment arrangement, decrease for tax withholding obligation   $ (155) $ 0   $ (1) $ 0   $ 1 $ 0       $ (155) $ 0
Stock Repurchased During Period, Shares 0                          
Ending balance (in shares) at Sep. 30, 2024 48,341,000     80,966,000                    
Ending balance at Sep. 30, 2024 $ 111,312     $ 811     $ 268,066     $ 31,459 $ 0 $ (189,024)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Treasury Stock, Common, Shares 32,625,000                     32,625,000    
v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Cash flows from operating activities:            
Net income (loss) $ (200)   $ 1,010 $ (769) $ 1,343  
Adjustments to reconcile net income to net cash flows from operating activities:            
Depreciation       13,584 12,576  
Deferred income taxes       (350) (3,179)  
Amortization of deferred financing costs       109 109  
Stock-based compensation       6,118 7,722  
Income (Loss) from Equity Method Investments       (325) (428)  
Change in accrual for unrecognized tax benefits       174 388  
Impairment on investment   $ 400 300 400 300 $ 2,300
Changes in operating assets and liabilities:            
Accounts receivable       2,572 2,236  
Prepaid expenses and other assets       489 (750)  
Capitalized contract costs       (714) 3,273  
Accounts payable and accrued expenses       (1,808) (7,799)  
Income taxes receivable/payable       (96) 73  
Deferred revenue       (3,058) (2,020)  
Other, net       350 494  
Net cash flows from operating activities       16,676 13,724  
Proceeds from Sale of Equity Method Investments       0 4,941  
Cash flows from (used in) investing activities:            
Purchases of fixed assets       (11,146) (14,988)  
Net cash flows used in investing activities       (11,146) (10,047)  
Cash flows from (used in) financing activities:            
Payments on long-term debt       (19,000) (23,000)  
Proceeds from long-term debt       13,000 33,000  
Payments under stock repurchase plan       0 (6,896)  
Purchase of treasury stock related to tax withholdings on vested equity awards       (1,808) (6,211)  
Proceeds from Issuance of Common Stock       145 148  
Net cash flows used in financing activities       (7,663) (2,959)  
Net change in cash for the period       (2,133) 718  
Cash, beginning of period   $ 4,206   4,206 3,006  
Cash, end of period $ 2,073   $ 3,724 2,073 3,724 $ 3,006
Equity securities, FV-NI, gain (loss)       $ 0 $ (614)  
v3.24.3
ORGANIZATION AND PRINCIPAL ACTIVITIES (Notes)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of DHI Group, Inc. (“DHI” or the “Company” or "we," "our" or "us") have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in annual audited consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been omitted and condensed pursuant to such rules and regulations. In the opinion of the Company’s management, all adjustments have been made to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. Although the Company believes that the disclosures are adequate to make the information presented not misleading, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report on Form 10-K”). Operating results for the three and nine-month periods ended September 30, 2024 are not necessarily indicative of the results to be achieved for the full year or any other future period.

Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Management believes the most complex and sensitive judgments, because of their significance to the condensed consolidated financial statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Actual results could differ materially from management’s estimates reported in the condensed consolidated financial statements and footnotes thereto. There have been no significant changes in the Company’s assumptions regarding critical accounting estimates during the three and nine-month periods ended September 30, 2024.

The Company allocates resources and assesses financial performance on a consolidated basis, as all services pertain to the Company's Tech-focused strategy. As a result, the Company has a single reportable segment, Tech-focused, which includes the Dice and ClearanceJobs brands, as well as corporate related costs. All operations are in the United States.
v3.24.3
SIGNIFCANT ACCOUNTING POLICIES (Notes)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
2.    NEW ACCOUNTING STANDARDS

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes how entities are to account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The guidance replaces the then-current "incurred loss" model with an "expected loss" model that requires consideration of a broader range of information to estimate expected credit losses over the lifetime of a financial asset. ASU 2016-13 is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2022 for Smaller Reporting Companies. On January 1, 2023, under the modified retrospective method as required by the standard, the Company recorded a cumulative-effect adjustment of $0.3 million to increase accumulated earnings and reduce the allowance for doubtful accounts. Prior period amounts were not adjusted, and will continue to be reported under the accounting standards in effect for the period presented.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new accounting standard relates to disclosures about a public entity’s reportable segments and provides more detailed information about a reportable segment’s expenses. The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024, with retrospective application required. We are evaluating the effect of the standard on our consolidated financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The new accounting standard requires more detailed disclosures regarding the effective tax rate reconciliation and income taxes paid. The standard is effective for fiscal years beginning after December 15, 2024, and may be applied on either a prospective or retrospective basis, with early adoption permitted. We are evaluating the effect of the standard on our consolidated financial statement disclosures.
v3.24.3
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
The FASB ASC topic on Fair Value Measurements and Disclosures defines fair value, establishes a framework for measuring fair value and requires certain disclosures for each major asset and liability category measured at fair value on either a recurring
or nonrecurring basis. As a basis for considering assumptions, a three-tier fair value hierarchy is used, which prioritizes the inputs used in measuring fair value as follows:
 
•Level 1 – Quoted prices for identical instruments in active markets.
•Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
•Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, other assets, accounts payable and accrued expenses and long-term debt approximate their fair values. The estimated fair value of long-term debt is based on Level 2 inputs.

Certain assets and liabilities are measured at fair value on a non-recurring basis as they are subject to fair value adjustments in certain circumstances, for example, when there is evidence of impairment. Such instruments are not measured at fair value on an ongoing basis. These assets include equity investments, operating lease right-of-use assets, and goodwill and intangible assets which resulted from prior acquisitions. Items valued using such internally generated valuation techniques are classified according to the lowest level input or value driver that is significant to the valuation. Thus, an item may be classified in Level 3 even though there may be some significant inputs that are readily observable.
v3.24.3
Revenue Recognition (Notes)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition REVENUE RECOGNITION
The Company recognizes revenue when control of the promised goods or services is transferred to our customers at an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized net of customer discounts ratably over the service period. Customer billings delivered in advance of services being rendered are recorded as deferred revenue and recognized over the service period. The Company generates revenue from recruitment packages, advertising, classifieds, and virtual and live career fair and recruitment event booth rentals.

Disaggregation of Revenue

Our brands primarily serve the technology and security cleared professions. The following table provides information about disaggregated revenue by brand and includes a reconciliation of the disaggregated revenue (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
   ClearanceJobs$13,415 $12,663 $39,538 $36,639 
   Dice(1)
21,868 24,770 67,603 77,952 
Total$35,283 $37,433 $107,141 $114,591 
(1) Includes Dice and Career Events

Contract Balances

The following table provides information about opening and closing balances of receivables and contract liabilities from contracts with customers as required under Topic 606 (in thousands):

As of September 30, 2024As of December 31, 2023
Receivables$19,653 $22,225 
Short-term contract liabilities (deferred revenue)46,113 49,463 
Long-term contract liabilities (deferred revenue)800 508 

We receive payments from customers based upon contractual billing schedules; accounts receivable are recorded when customers are invoiced per the contractual billings schedules. As the Company's standard payment terms are less than one year,
the Company elected the practical expedient, where applicable. As a result, the Company does not consider the effects of a significant financing component. Contract liabilities include customer billings delivered in advance of performance under the contract, and associated revenue is realized when services are rendered under the contract.

Receivables increase due to customer billings and decrease by cash collected from customers. Contract liabilities increase due to customer billings and are decreased as performance obligations are satisfied under the contracts.

The Company recognized the following revenue as a result of changes in the contract liability balances in the respective periods (in thousands):
Three Months EndedNine Months Ended
September 30, 2024September 30, 2023September 30, 2024September 30, 2023
Revenue recognized in the period from:
Amounts included in the contract liability at the beginning of the period$26,882 $26,958 $45,444 $44,660 

The following table includes estimated deferred revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period (in thousands):

Remainder of 2024202520262027Total
Tech-focused$25,202 $21,128 $422 $161 $46,913 

Credit Losses

The Company is exposed to credit losses through the inability of its customers to make required payments on accounts receivable. The Company segments accounts receivable based on credit risk characteristics and estimates future losses for each segment based on historical trends and current market conditions, as applicable. Expected losses on accounts receivable are recorded as allowance for doubtful accounts in the condensed consolidated balance sheets and as an expense in the condensed consolidated statement of operations. The portion of accounts receivable that is reflected as deferred revenue in the condensed consolidated balance sheets is not considered at risk for credit losses. If the financial condition of DHI’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.
v3.24.3
RESTRUCTURE COSTS
 9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
RESTRUCTURE COSTS RESTRUCTURING
In May 2023, the Company announced an organizational restructuring intended to streamline its operations, drive business objectives, reduce operating expenses and improve operating margins. The restructuring included a reduction of the Company’s then-current workforce by approximately 10%. As a result of the restructuring, the Company recognized charges of $0.3 million and $2.4 million, respectively, for the three and nine-month periods ended September 30, 2023. The charges for the three and nine-month periods ended September 30, 2023 consisted of $0.1 million and $1.9 million, respectively, of employee severance costs, of which $0.9 million and $1.4 million, respectively, was paid during the periods, and $0.2 million and $0.5 million, respectively, of stock-based compensation related to the acceleration of restricted stock and performance-based restricted stock units.

In July 2024, the Company announced an additional organizational restructuring intended to streamline its operations, drive business objectives, and reduce operating costs. This included a reduction of the Company’s then-current workforce by approximately 7%. As a result of the restructuring, the Company recognized a charge of $1.1 million during the third quarter of 2024 related to employee severance costs, of which $0.8 million was paid during the period.
v3.24.3
LEASES
 9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
LEASES LEASES
The Company has operating leases for corporate office space and certain equipment. The leases have original terms from one year to ten years, some of which include options to renew the lease, and are included in the lease term when it is reasonably certain that the Company will exercise the option. No leases include options to purchase the leased property. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. We do not have any lease agreements with related parties.
The components of lease cost were as follows (in thousands):

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Operating lease cost(1)
$419 $352 $1,255 $1,530 
Sublease income(20)(25)(50)(324)
      Total lease cost$399 $327 $1,205 $1,206 
(1) Includes short-term lease costs and variable lease costs, which are immaterial.

Supplemental cash flow information related to leases was as follows (in thousands):

For the Nine Months Ended September 30,
20242023
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases$1,110 $1,832 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$2,930 $— 

Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount):

September 30, 2024December 31, 2023
Operating lease right-of-use-assets (as reported)$6,810 $4,759 
Operating lease liabilities - current (as reported)1,857 2,006 
Operating lease liabilities - non-current (as reported)9,170 6,543 
Total operating lease liabilities$11,027 $8,549 
Weighted Average Remaining Lease Term (in years)
Operating leases7.6 years6.2 years
Weighted Average Discount Rate
Operating leases5.5 %4.5 %

The Company reviews its right-of-use ("ROU") assets for impairment if indicators of impairment exist. The impairment review process compares the fair value of the ROU asset to its carrying value. If the carrying value exceeds the fair value, an impairment loss is recorded. No impairment was recorded during the three and nine month periods ended September 30, 2024 and 2023.
As of September 30, 2024, future operating lease payments were as follows (in thousands):

Operating Leases
Oct 1, 2024 through December 31, 2024$554 
20252,206 
20262,211 
20271,331 
20281,276 
2029 and thereafter6,156 
Total lease payments$13,734 
Less: imputed interest(2,707)
Total$11,027 
As of September 30, 2024 the Company has no additional operating or finance leases that have not yet commenced.
v3.24.3
INVESTMENTS (Notes)
 9 Months Ended
Sep. 30, 2024
Investments [Abstract]  
Investment
eFinancialCareers

On June 30, 2021, the Company transferred majority ownership and control of its eFinancialCareers ("eFC") business to eFC's management, while retaining a 40% common share interest with zero proceeds received from the transfer. During the third quarter of 2023, the Company sold a portion of its ownership in eFC reducing its total interest in eFC from 40% to 10%. As a result of the sale, the Company received cash of $4.9 million and recognized a $0.6 million gain, which included a $0.2 million charge related to accumulated foreign currency loss that was previously a reduction to equity.

eFC is a financial services careers website, operating websites in multiple markets in four languages mainly across the United Kingdom, Continental Europe, Asia, the Middle East and North America. Professionals from across many sectors of the financial services industry, including asset management, risk management, investment banking, and information technology, use eFC to advance their careers. The Company has evaluated its common share interest in the eFC business and has determined the investment meets the definition and criteria of a variable interest entity ("VIE"). The Company evaluated the VIE and determined that the Company does not have a controlling financial interest in the VIE, as the Company does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance. The common share interest is being accounted for under the equity method of accounting as the Company has the ability to exercise significant influence over eFC. The investment was recorded at its fair value on June 30, 2021, the date of transfer, which was $3.6 million. The Company's equity in the net assets of eFC as of June 30, 2021 was $2.2 million. The difference between the Company's recorded value and its equity in net assets of eFC was reduced during the third quarter of 2023, as described above, as the Company reduced its ownership in eFC. The remaining basis difference at the time of sale was $0.3 million and is being amortized against the recorded value of the investment in accordance with ASC 323 Investments - Equity Method and Joint Ventures. Amortization expense during the three and nine-month periods ended September 30, 2024 and 2023 was not significant. The recorded value is further adjusted based on the Company's proportionate share of eFC's net income and is recorded three months in arrears. The Company recorded income related to its proportionate share of eFC's net income, net of currency translation adjustments and amortization of the basis difference, of zero and $0.3 million for the three and nine month periods ended September 30, 2024, respectively, and recorded $0.2 million and $0.4 million for the three and nine month periods ended September 30, 2023, respectively.

Other

During 2021, the Company invested $3.0 million through a subordinated convertible promissory note (the "Note") with a values-based career destination company that allows the next generation workforce to search for jobs at companies whose people, perks and values align with their unique professional needs. The investment was recorded as a trading security at fair value and was recorded at $3.0 million as of December 31, 2021.

In the third quarter of 2022, the Note was converted into preferred shares representing 4.9% of the outstanding equity in the underlying business, on a fully-diluted basis. The Company's preferred shares are substantially similar to shares purchased by a
third party investor that resulted in such investor becoming the majority owner of the business. Therefore the Company's shares in the business were recorded at fair value based on the price per share realized in the conversion. The value of the Company's investment was $0.7 million as of December 31, 2022 and was recorded as an investment in the consolidated balance sheet. Accordingly, the Company recognized an impairment loss during the year ended December 31, 2022 of $2.3 million.

During the third quarter of 2023, the investment's financial position deteriorated. To meet its financial obligations, the investment issued convertible debt at a price that indicated the value of the investment had declined. As such, the Company revalued its investment to $0.4 million and accordingly, recognized an impairment loss of $0.3 million during the third quarter of 2023.

During the first quarter of 2024, the investment's financial position further deteriorated. To meet its financial obligations, the investment issued additional convertible debt at a price that indicated the value of the investment had declined. As such, the Company revalued its investment to zero and accordingly, recognized an impairment loss of $0.4 million during the first quarter of 2024. The Company's ownership of the investment, on a fully diluted basis, as of September 30, 2024 is less than 0.10%.

At September 30, 2024, the Company held preferred stock representing a 7.3% interest in the fully diluted shares of a tech skills assessment company. The investment is recorded at zero as of September 30, 2024 and December 31, 2023. The Company recorded no gain or loss related to the investment during the three and nine month periods ended September 30, 2024 and 2023.
v3.24.3
ACQUIRED INTANGIBLE ASSETS, NET
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure ACQUIRED INTANGIBLE ASSETS, NET
Considering the recognition of the Dice brand, its long history, awareness in the talent acquisition and staffing services market, and the intended use, the remaining useful life of the Dice trademarks and brand name was determined to be indefinite. We determine whether the carrying value of recorded indefinite-lived acquired intangible assets is impaired on an annual basis or more frequently if indicators of potential impairment exist. The annual impairment test for the Dice trademarks and brand name is performed on October 1 of each year. The impairment review process compares the fair value of the indefinite-lived acquired intangible assets to its carrying value. If the carrying value exceeds the fair value, an impairment loss is recorded. There were no indicators of impairment for the Dice trademarks and brand name for the three and nine month periods ended September 30, 2024.

As of September 30, 2024 and December 31, 2023 the Company had an indefinite-lived acquired intangible asset of $23.8 million related to the Dice trademarks and brand name. No impairment was recorded during the three and nine month periods ended September 30, 2024 and 2023.
The determination of whether or not indefinite-lived acquired intangible assets have become impaired involves a significant level of judgment in the assumptions underlying the approach used to determine the value of the indefinite-lived acquired intangible assets. Fair values are determined using a profit allocation methodology which estimates the value of the trademarks and brand name by capitalizing the profits saved because the company owns the asset. We consider factors such as historical performance, anticipated market conditions, operating expense trends and capital expenditure requirements. Changes in our strategy and/or changes in market conditions could significantly impact these judgments and require adjustments to recorded amounts of intangible assets. If projections are not achieved, the Company could realize an impairment in the foreseeable future.
v3.24.3
GOODWILL (Notes)
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Disclosure [Text Block] .   GOODWILL
Goodwill as of September 30, 2024 and December 31, 2023, which was allocated to the Tech-focused reporting unit, was $128.1 million.

The annual impairment test for the Tech-focused reporting unit is performed on October 1 of each year. The results of the impairment test indicated that the fair value of the Tech-focused reporting unit was substantially in excess of the carrying value as of October 1, 2023. Results for the Tech-focused reporting unit through September 30, 2024 and estimated future results as of September 30, 2024 approximate the projections used in the October 1, 2023 analysis. As a result, the Company believes it is not more likely than not that the fair value of the reporting unit is less than the carrying value as of September 30, 2024. Therefore, no quantitative impairment test was performed as of September 30, 2024. No impairment was recorded during the three and nine month periods ended September 30, 2024 and 2023.
The Company’s ability to achieve the projections used in the October 1, 2023 analysis may be impacted by, among other things, general market conditions, competition in the technology recruiting market, challenges in developing and introducing new products and product enhancements to the market and the Company’s ability to attribute value delivered to customers. If future cash flows that are attributable to the Tech-focused reporting unit are not achieved, the Company could realize an impairment in a future period.
v3.24.3
INDEBTEDNESS
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Debt Disclosure INDEBTEDNESS
Credit Agreement—In June 2022, the Company, together with Dice Inc. (a wholly-owned subsidiary of the Company) and its wholly-owned subsidiary, Dice Career Solutions, Inc. (collectively, the “Borrowers”), entered into a Third Amended and Restated Credit Agreement (the “Credit Agreement”), which matures in June 2027. The Credit Agreement provides for a revolving loan facility of $100 million, with an expansion option of $50 million, bringing the total facility to $150 million, as permitted under the terms of the Credit Agreement. At the closing of the Credit Agreement, the Company borrowed $30 million to repay, in full, all outstanding indebtedness, including accrued interest, under the previous credit agreement. Unamortized debt issuance costs from the previous credit agreement of $0.2 million and debt issuance costs of $0.5 million related to the new agreement were recorded as other assets on the condensed consolidated balance sheets and are recorded to interest expense over the term of the Credit Agreement.

Borrowings under the Credit Agreement denominated in U.S. dollars bear interest, payable at least quarterly, at the Company’s option, at the Secured Overnight Financing Rate ("SOFR") or a base rate plus a margin. Borrowings under the Credit Agreement denominated in pounds sterling, if any, bear interest at the Sterling Overnight Index Average ("SONIA") rate plus a margin. The margin ranges from 2.00% to 2.75% on SOFR and SONIA loans and 1.00% to 1.75% on base rate loans, determined by the Company’s most recent consolidated leverage ratio, plus an additional spread of 0.10%. The Company incurs a commitment fee ranging from 0.35% to 0.50% on any unused capacity under the revolving loan facility, determined by the Company’s most recent consolidated leverage ratio. All borrowings as of September 30, 2024 and December 31, 2023 were in U.S. dollars. The facility may be prepaid at any time without penalty.

The Credit Agreement contains various affirmative and negative covenants and also contains certain financial covenants, including a consolidated leverage ratio and a consolidated interest coverage ratio. Borrowings are allowed under the Credit Agreement to the extent the consolidated leverage ratio is equal to or less than 2.50 to 1.00, subject to the terms of the Credit Agreement. Negative covenants include restrictions on incurring certain liens; making certain payments, such as stock repurchases and dividend payments; making certain investments; making certain acquisitions; making certain dispositions; and incurring additional indebtedness. Restricted payments are allowed under the Credit Agreement to the extent the consolidated leverage ratio, calculated on a pro forma basis, is equal to or less than 2.00 to 1.00, plus an additional $7.5 million of restricted payments each fiscal year, as described in the Credit Agreement. The Credit Agreement also provides that the payment of obligations may be accelerated upon the occurrence of events of default, including, but not limited to, non-payment, change of control, or insolvency. As of September 30, 2024, the Company was in compliance with all of the financial covenants under the Credit Agreement.

The obligations under the Credit Agreement are guaranteed by one of the Company’s wholly-owned subsidiaries and secured by substantially all of the assets of the Borrowers and the guarantors.
The amounts borrowed as of September 30, 2024 and December 31, 2023 are as follows (dollars in thousands):

 September 30,
2024		December 31,
2023
Long-term debt under revolving credit facility(1)
$32,000 $38,000 
Available to be borrowed under revolving facility(2)
$58,000 $62,000 
Interest rate and margin:
Interest margin(3)
2.10 %2.35 %
Actual interest rates(4)
6.97 %7.71 %
Commitment fee0.35 %0.40 %
(1) In connection with the Credit Agreement, the Company had deferred financing costs of $0.7 million and accumulated amortization of $0.3 million recorded in other assets on the condensed consolidated balance sheets.
(2) The amount available to be borrowed is subject to certain limitations, such as a consolidated leverage ratio which generally limits borrowings to 2.5 times annual Adjusted EBITDA, as defined in the Credit Agreement.
(3) Computed as the weighted average interest margin on all borrowings, including an additional spread of 0.10%.
(4) Computed as the weighted average interest rate on all borrowings.

There are no scheduled principal payments until maturity of the Credit Agreement in June 2027.
v3.24.3
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies .    COMMITMENTS AND CONTINGENCIES
Litigation

The Company is subject to various claims from taxing authorities, lawsuits and other complaints arising in the ordinary course of business. The Company records provisions for losses when claims become probable and the amounts are reasonably estimable. Although the outcome of these legal matters, except as described below and recorded in the condensed consolidated financial statements, cannot be determined, it is the opinion of management that the final resolution of these matters will not have a material effect on the Company’s financial condition, operations or liquidity.

Tax Contingencies

The Company operates in a number of tax jurisdictions and is routinely subject to examinations by various tax authorities with respect to income taxes and indirect taxes. The determination of the Company’s liability for taxes requires judgment and estimation. The Company has reserved for potential examination adjustments to our provision for income taxes and accrual of indirect taxes in amounts which the Company believes are reasonable.
v3.24.3
EQUITY TRANSACTIONS (Notes)
 9 Months Ended
Sep. 30, 2024
Equity, Class of Treasury Stock [Line Items]  
Stockholders' Equity Note Disclosure [Text Block] EQUITY TRANSACTIONS
Stock Repurchase Plans—The Company's Board of Directors ("Board") has previously approved stock repurchase programs that permitted the Company to repurchase its common stock. Management had discretion in determining the conditions under which shares may be purchased from time to time. The number, price, structure, and timing of the repurchases, if any, were at our sole discretion and future repurchases were evaluated by us depending on market conditions, liquidity needs, restrictions under the agreements governing our indebtedness, and other factors. Share repurchases could be made in the open market or in privately negotiated transactions. The repurchase authorizations did not oblige us to acquire any particular amount of our common stock. The Board could have suspended, modified, or terminated a repurchase program at any time without prior notice. The following table summarizes the stock repurchase plans previously approved by the Board:
February 2022 to February 2023(1)
February 2023 to February 2024(2)
Approval DateFebruary 2022February 2023
Authorized Repurchase Amount of Common Stock$15 million$10 million
(1) During February 2023, the stock repurchase program approved in February 2022 expired with a total of 2.6 million shares purchased for $14.7 million.
(2) During February 2024, the stock repurchase program approved in February 2023 expired with a total of 1.4 million shares purchased for $5.2 million.

As of September 30, 2024 the Company has no stock repurchase programs and all previously approved stock repurchase programs have expired in accordance with their terms.

Purchases of the Company's common stock pursuant to the stock repurchase plans were as follows:

Nine Months Ended September 30,
20242023
Shares repurchased— 1,661,278 
Average purchase price per share(1)
$— $4.17 
Dollar value of shares repurchased (in thousands)(1)
$— $6,928 
(1) Average price paid per share and dollar value of shares repurchased include costs associated with the repurchases.

There were no repurchases of the Company's common stock during the three month periods ended September 30, 2024 and 2023 and there were no unsettled share repurchases as of September 30, 2024 and 2023.

Stock Repurchases Pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated—Under the 2022 Omnibus Equity Award Plan, as Amended and Restated (as defined below), and as further described in note 13 to the condensed consolidated financial statements, the Company repurchases its common stock withheld for income tax from the vesting of employee restricted stock or Performance-Based Restricted Stock Units (“PSUs”). The Company remits the value, which is based on the closing share price on the vesting date, of the common stock withheld to the appropriate tax authority on behalf of the employee and the related shares become treasury stock.

Purchases of the Company’s common stock pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Shares repurchased upon restricted stock/PSU vesting71,076 218,432 736,144 1,143,583 
Average purchase price per share$2.17 $3.76 $2.46 $5.43 
Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands)$154 $821 $1,808 $6,211 

No shares of the Company's common stock were purchased other than through the stock repurchase plans and the 2022 Omnibus Equity Award Plan, as Amended and Restated, as described above.
v3.24.3
STOCK BASED COMPENSATION
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK BASED COMPENSATION STOCK-BASED COMPENSATION
On July 13, 2022, the stockholders of the Company approved the DHI Group, Inc. 2022 Omnibus Equity Award Plan, which had been previously approved by the Company's Board of Directors on May 13, 2022 (the "2022 Omnibus Equity Award Plan"). The 2022 Omnibus Equity Award Plan generally mirrors the terms of the Company's prior omnibus equity award plan, which expired in accordance with its terms on April 20, 2022 (the "2012 Omnibus Equity Award Plan"). On April 26, 2023, the stockholders of the Company approved the DHI Group, Inc. 2022 Omnibus Equity Award Plan, as Amended and Restated, which had been previously approved by the Company’s Board of Directors on March 16, 2023 (the "2022 Omnibus Equity Award Plan, as Amended and Restated"). The 2022 Omnibus Equity Award Plan was amended and restated to, among other things, increase the number of shares of common stock authorized for issuance as equity awards under the plan by 2.9 million shares. The Company has previously granted restricted stock and PSUs to certain employees and directors pursuant to the 2012
Omnibus Equity Award Plan and the 2022 Omnibus Equity Award Plan and will continue to grant restricted stock and PSUs to certain employees and directors pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated. The Company also offers an Employee Stock Purchase Plan.

The Company recorded total stock-based compensation expense of $1.8 million and $6.1 million during the three and nine month periods ended September 30, 2024, respectively, and $2.2 million and $7.7 million during the three and nine month periods ended September 30, 2023. At September 30, 2024, there was $9.6 million of unrecognized compensation expense related to unvested awards, which is expected to be recognized over a weighted-average period of approximately 0.9 years.

Restricted Stock—Restricted stock is granted to employees of the Company and its subsidiaries, and to non-employee members of the Company’s Board. These shares are part of the compensation plan for services provided by the employees or Board members. The closing price of the Company’s stock on the date of grant is used to determine the fair value of the grants. The expense related to restricted stock grants is recorded over the vesting period as described below. There was no cash flow impact resulting from the grants.

Restricted stock vests in various increments on the anniversaries of each grant, subject to the recipient’s continued employment or service through each applicable vesting date. Vesting occurs over one year for Board members and over three years for employees.

A summary of the status of restricted stock awards as of September 30, 2024 and 2023 and the changes during the periods then ended is presented below:
Three Months Ended September 30, 2024Three Months Ended September 30, 2023
SharesWeighted- Average Fair Value at Grant DateSharesWeighted- Average Fair Value at Grant Date
Non-vested at beginning of the period2,982,437 $3.52 2,574,925 $4.82 
Granted196,000 $2.11 307,174 $3.57 
Forfeited(121,509)$3.88 (289,002)$5.45 
Vested(219,696)$4.01 (360,325)$4.09 
Non-vested at end of period2,837,232 $3.37 2,232,772 $4.69 
Expected to vest 2,837,232 $3.37 2,232,772 $4.69 

Nine Months Ended September 30, 2024Nine Months Ended September 30, 2023
SharesWeighted- Average Fair Value at Grant DateSharesWeighted- Average Fair Value at Grant Date
Non-vested at beginning of the period2,333,436 $4.55 2,639,286 $3.96 
Granted1,857,739 $2.49 1,590,172 $5.17 
Forfeited(176,511)$3.83 (475,681)$5.24 
Vested(1,177,432)$4.25 (1,521,005)$3.76 
Non-vested at end of period2,837,232 $3.37 2,232,772 $4.69 
Expected to vest2,837,232 $3.37 2,232,772 $4.69 

PSUs—PSUs are granted to employees of the Company and its subsidiaries. These shares are granted under compensation agreements that are for services provided by the employees. The fair value of the PSUs is measured at the grant date fair value of the award, which was determined based on an analysis of the probable performance outcomes. The performance period is over one year and is based on the achievement of bookings targets during the year of grant, as defined in the applicable award agreement. The earned shares will then vest over a three year period, one-third on each of the first, second, and third anniversaries of the grant date, or if later, the date the Compensation Committee certifies the performance results with respect to the performance period.

There was no cash flow impact resulting from the grants.
A summary of the status of PSUs as of September 30, 2024 and 2023 and the changes during the periods then ended is presented below:

Three Months Ended September 30, 2024Three Months Ended September 30, 2023
SharesWeighted- Average Fair Value at
Grant Date		SharesWeighted- Average Fair Value at
Grant Date
Non-vested at beginning of the period1,544,346 $3.50 2,045,427 $4.78 
Granted— $— 55,128 $3.56 
Forfeited(30,568)$3.52 (429,685)$5.28 
Vested— $— (182,776)$3.77 
Non-vested at end of period1,513,778 $3.50 1,488,094 $4.71 
Expected to vest1,513,778 $3.50 1,488,094 $4.71 

Nine Months Ended September 30, 2024Nine Months Ended September 30, 2023
SharesWeighted- Average Fair Value at
Grant Date		SharesWeighted- Average Fair Value at
Grant Date
Non-vested at beginning of the period1,616,962 $4.52 2,086,932 $3.48 
Granted(1)
960,000 $2.54 1,412,715 $5.54 
Forfeited(2)
(283,782)$4.80 (592,703)$5.14 
Vested(779,402)$3.99 (1,418,850)$3.54 
Non-vested at end of period1,513,778 $3.50 1,488,094 $4.71 
Expected to vest1,513,778 $3.50 1,488,094 $4.71 
(1) PSUs granted during the nine months ended September 30, 2023 includes 587,587 additional PSUs related to the bookings achievement for the performance period ended December 31, 2022.
(2) PSUs forfeited during the nine months ended September 30, 2024 includes 230,291 PSUs related to the bookings achievement for the performance period ended December 31, 2023.
Employee Stock Purchase Plan—On March 11, 2020 the Company's Board of Directors adopted an Employee Stock Purchase Plan ("ESPP"). The ESPP was approved by the Company's stockholders on April 21, 2020. The ESPP provides eligible employees the opportunity to purchase shares of the Company's common stock through payroll deductions during six-month offering periods. The purchase price per share of common stock is 85% of the lower of the closing stock price on the first or last trading day of each offering period. The offering periods are January 1 to June 30 and July 1 to December 31. The maximum number of shares of common stock available for purchase under the ESPP is 500,000, subject to adjustment as provided under the ESPP. Individual employee purchases are limited to $25,000 per calendar year, based on the fair market value of the shares on the purchase date. No shares were issued during the three months ended September 30, 2024 and 2023. During the nine months ended September 30, 2024 and 2023, 81,874 and 45,374 shares, respectively, were issued under the plan.
v3.24.3
EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE
Basic earnings per share (“EPS”) is computed based on the weighted-average number of shares of common stock outstanding. Diluted EPS is computed based on the weighted-average number of shares of common stock outstanding plus common stock equivalents, where dilutive. The following is a calculation of basic and diluted earnings per share and weighted-average shares outstanding (in thousands, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
 2024202320242023
Net income (loss)$(200)$1,010 $(769)$1,343 
Weighted-average shares outstanding—basic44,873 43,405 44,550 43,582 
Add shares issuable from stock-based awards(1)
— 919 — 997 
Weighted-average shares outstanding—diluted44,873 44,324 44,550 44,579 
Basic earnings (loss) per share$— $0.02 $(0.02)$0.03 
Diluted earnings (loss) per share$— $0.02 $(0.02)$0.03 
Dilutive shares issuable from unvested equity awards(1)
— 919 — 997 
Anti-dilutive shares issuable from unvested equity awards(2)
3,271 1,961 3,325 2,217 
(1) During each of the three and nine months ended September 30, 2024, 0.4 million shares were excluded from the computation of shares contingently issuable upon exercise as we recognized a net loss.
(2) Represents outstanding stock-based awards that were anti-dilutive and excluded from the calculation of diluted earnings per share.
v3.24.3
INCOME TAXES (Notes)
 9 Months Ended
Sep. 30, 2024
Income Tax Contingency [Line Items]  
Income Tax Disclosure [Text Block] INCOME TAXES
The Company’s effective tax rate was (91)% and 139% for the three and nine months ended September 30, 2024, respectively, and 43% and (47)% for the three and nine months ended September 30, 2023, respectively. The following items caused the effective rate to differ from the statutory rate:

•Tax expense of $0.1 million and $2.0 million during the three and nine months ended September 30, 2024, respectively, and tax benefits of $0.4 million during the nine months ended September 30, 2023, from the tax impacts of share-based compensation awards.
•Tax expense of $0.2 million during the nine months ended September 30, 2024, from state taxes related to research and development expenditures.
•Tax benefits of $0.4 million during the nine months ended September 30, 2023, from research tax credits.
•Tax expense of $0.1 million during the three months ended September 30, 2023, from deduction limitations on executive compensation.
•Tax expense of $0.1 million during the three months ended September 30, 2023, from a valuation allowance related to the impairment of an investment.
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net income (loss) $ (200) $ 1,010 $ (769) $ 1,343
v3.24.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2024
shares
Sep. 30, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Evan Lesser [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On August 22, 2024, Evan Lesser, one of our officers, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 55,000 shares of our common stock from November 29, 2024 until December 31, 2025.
Name Evan Lesser  
Title officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 22, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 397 days  
Aggregate Available 55,000 55,000
v3.24.3
Revenue Recognition (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The following table provides information about disaggregated revenue by brand and includes a reconciliation of the disaggregated revenue (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
   ClearanceJobs$13,415 $12,663 $39,538 $36,639 
   Dice(1)
21,868 24,770 67,603 77,952 
Total$35,283 $37,433 $107,141 $114,591 
(1) Includes Dice and Career Events
Schedule of Contract Balances
The following table provides information about opening and closing balances of receivables and contract liabilities from contracts with customers as required under Topic 606 (in thousands):

As of September 30, 2024As of December 31, 2023
Receivables$19,653 $22,225 
Short-term contract liabilities (deferred revenue)46,113 49,463 
Long-term contract liabilities (deferred revenue)800 508 
The Company recognized the following revenue as a result of changes in the contract liability balances in the respective periods (in thousands):
Three Months EndedNine Months Ended
September 30, 2024September 30, 2023September 30, 2024September 30, 2023
Revenue recognized in the period from:
Amounts included in the contract liability at the beginning of the period$26,882 $26,958 $45,444 $44,660 
Schedule of Expected Timing of Satisfaction for Performance Obligations
The following table includes estimated deferred revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period (in thousands):

Remainder of 2024202520262027Total
Tech-focused$25,202 $21,128 $422 $161 $46,913 

Credit Losses

The Company is exposed to credit losses through the inability of its customers to make required payments on accounts receivable. The Company segments accounts receivable based on credit risk characteristics and estimates future losses for each segment based on historical trends and current market conditions, as applicable. Expected losses on accounts receivable are recorded as allowance for doubtful accounts in the condensed consolidated balance sheets and as an expense in the condensed consolidated statement of operations. The portion of accounts receivable that is reflected as deferred revenue in the condensed consolidated balance sheets is not considered at risk for credit losses. If the financial condition of DHI’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.
v3.24.3
LEASES (Tables)
 9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
Lease, Cost
The components of lease cost were as follows (in thousands):

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Operating lease cost(1)
$419 $352 $1,255 $1,530 
Sublease income(20)(25)(50)(324)
      Total lease cost$399 $327 $1,205 $1,206 
(1) Includes short-term lease costs and variable lease costs, which are immaterial.

Supplemental cash flow information related to leases was as follows (in thousands):

For the Nine Months Ended September 30,
20242023
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases$1,110 $1,832 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$2,930 $— 
Supplemental Balance Sheet Information
Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount):

September 30, 2024December 31, 2023
Operating lease right-of-use-assets (as reported)$6,810 $4,759 
Operating lease liabilities - current (as reported)1,857 2,006 
Operating lease liabilities - non-current (as reported)9,170 6,543 
Total operating lease liabilities$11,027 $8,549 
Weighted Average Remaining Lease Term (in years)
Operating leases7.6 years6.2 years
Weighted Average Discount Rate
Operating leases5.5 %4.5 %
Schedule of Maturities of Lease Liabilities were as follows (in thousands):
Operating Leases
Oct 1, 2024 through December 31, 2024$554 
20252,206 
20262,211 
20271,331 
20281,276 
2029 and thereafter6,156 
Total lease payments$13,734 
Less: imputed interest(2,707)
Total$11,027 
v3.24.3
INDEBTEDNESS (Tables)
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
The amounts borrowed as of September 30, 2024 and December 31, 2023 are as follows (dollars in thousands):

 September 30,
2024		December 31,
2023
Long-term debt under revolving credit facility(1)
$32,000 $38,000 
Available to be borrowed under revolving facility(2)
$58,000 $62,000 
Interest rate and margin:
Interest margin(3)
2.10 %2.35 %
Actual interest rates(4)
6.97 %7.71 %
Commitment fee0.35 %0.40 %
(1) In connection with the Credit Agreement, the Company had deferred financing costs of $0.7 million and accumulated amortization of $0.3 million recorded in other assets on the condensed consolidated balance sheets.
(2) The amount available to be borrowed is subject to certain limitations, such as a consolidated leverage ratio which generally limits borrowings to 2.5 times annual Adjusted EBITDA, as defined in the Credit Agreement.
(3) Computed as the weighted average interest margin on all borrowings, including an additional spread of 0.10%.
(4) Computed as the weighted average interest rate on all borrowings.
v3.24.3
EQUITY TRANSACTIONS (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Class of Treasury Stock [Table Text Block]
Stock Repurchase Plans—The Company's Board of Directors ("Board") has previously approved stock repurchase programs that permitted the Company to repurchase its common stock. Management had discretion in determining the conditions under which shares may be purchased from time to time. The number, price, structure, and timing of the repurchases, if any, were at our sole discretion and future repurchases were evaluated by us depending on market conditions, liquidity needs, restrictions under the agreements governing our indebtedness, and other factors. Share repurchases could be made in the open market or in privately negotiated transactions. The repurchase authorizations did not oblige us to acquire any particular amount of our common stock. The Board could have suspended, modified, or terminated a repurchase program at any time without prior notice. The following table summarizes the stock repurchase plans previously approved by the Board:
February 2022 to February 2023(1)
February 2023 to February 2024(2)
Approval DateFebruary 2022February 2023
Authorized Repurchase Amount of Common Stock$15 million$10 million
(1) During February 2023, the stock repurchase program approved in February 2022 expired with a total of 2.6 million shares purchased for $14.7 million.
(2) During February 2024, the stock repurchase program approved in February 2023 expired with a total of 1.4 million shares purchased for $5.2 million.
Schedule of Repurchase Agreements [Table Text Block]
Purchases of the Company's common stock pursuant to the stock repurchase plans were as follows:

Nine Months Ended September 30,
20242023
Shares repurchased— 1,661,278 
Average purchase price per share(1)
$— $4.17 
Dollar value of shares repurchased (in thousands)(1)
$— $6,928 
(1) Average price paid per share and dollar value of shares repurchased include costs associated with the repurchases.
Cash Proceeds Received and Tax Benefit from Share-based Payment Awards
Purchases of the Company’s common stock pursuant to the 2022 Omnibus Equity Award Plan, as Amended and Restated, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Shares repurchased upon restricted stock/PSU vesting71,076 218,432 736,144 1,143,583 
Average purchase price per share$2.17 $3.76 $2.46 $5.43 
Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands)$154 $821 $1,808 $6,211 

No shares of the Company's common stock were purchased other than through the stock repurchase plans and the 2022 Omnibus Equity Award Plan, as Amended and Restated, as described above.
v3.24.3
STOCK BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Share Activity
A summary of the status of restricted stock awards as of September 30, 2024 and 2023 and the changes during the periods then ended is presented below:
Three Months Ended September 30, 2024Three Months Ended September 30, 2023
SharesWeighted- Average Fair Value at Grant DateSharesWeighted- Average Fair Value at Grant Date
Non-vested at beginning of the period2,982,437 $3.52 2,574,925 $4.82 
Granted196,000 $2.11 307,174 $3.57 
Forfeited(121,509)$3.88 (289,002)$5.45 
Vested(219,696)$4.01 (360,325)$4.09 
Non-vested at end of period2,837,232 $3.37 2,232,772 $4.69 
Expected to vest 2,837,232 $3.37 2,232,772 $4.69 

Nine Months Ended September 30, 2024Nine Months Ended September 30, 2023
SharesWeighted- Average Fair Value at Grant DateSharesWeighted- Average Fair Value at Grant Date
Non-vested at beginning of the period2,333,436 $4.55 2,639,286 $3.96 
Granted1,857,739 $2.49 1,590,172 $5.17 
Forfeited(176,511)$3.83 (475,681)$5.24 
Vested(1,177,432)$4.25 (1,521,005)$3.76 
Non-vested at end of period2,837,232 $3.37 2,232,772 $4.69 
Expected to vest2,837,232 $3.37 2,232,772 $4.69 
A summary of the status of PSUs as of September 30, 2024 and 2023 and the changes during the periods then ended is presented below:

Three Months Ended September 30, 2024Three Months Ended September 30, 2023
SharesWeighted- Average Fair Value at
Grant Date		SharesWeighted- Average Fair Value at
Grant Date
Non-vested at beginning of the period1,544,346 $3.50 2,045,427 $4.78 
Granted— $— 55,128 $3.56 
Forfeited(30,568)$3.52 (429,685)$5.28 
Vested— $— (182,776)$3.77 
Non-vested at end of period1,513,778 $3.50 1,488,094 $4.71 
Expected to vest1,513,778 $3.50 1,488,094 $4.71 

Nine Months Ended September 30, 2024Nine Months Ended September 30, 2023
SharesWeighted- Average Fair Value at
Grant Date		SharesWeighted- Average Fair Value at
Grant Date
Non-vested at beginning of the period1,616,962 $4.52 2,086,932 $3.48 
Granted(1)
960,000 $2.54 1,412,715 $5.54 
Forfeited(2)
(283,782)$4.80 (592,703)$5.14 
Vested(779,402)$3.99 (1,418,850)$3.54 
Non-vested at end of period1,513,778 $3.50 1,488,094 $4.71 
Expected to vest1,513,778 $3.50 1,488,094 $4.71 
(1) PSUs granted during the nine months ended September 30, 2023 includes 587,587 additional PSUs related to the bookings achievement for the performance period ended December 31, 2022.
(2) PSUs forfeited during the nine months ended September 30, 2024 includes 230,291 PSUs related to the bookings achievement for the performance period ended December 31, 2023.
Weighted Average Remaining Contractual Life Employee Stock Purchase Plan—On March 11, 2020 the Company's Board of Directors adopted an Employee Stock Purchase Plan ("ESPP"). The ESPP was approved by the Company's stockholders on April 21, 2020. The ESPP provides eligible employees the opportunity to purchase shares of the Company's common stock through payroll deductions during six-month offering periods. The purchase price per share of common stock is 85% of the lower of the closing stock price on the first or last trading day of each offering period. The offering periods are January 1 to June 30 and July 1 to December 31. The maximum number of shares of common stock available for purchase under the ESPP is 500,000, subject to adjustment as provided under the ESPP. Individual employee purchases are limited to $25,000 per calendar year, based on the fair market value of the shares on the purchase date. No shares were issued during the three months ended September 30, 2024 and 2023. During the nine months ended September 30, 2024 and 2023, 81,874 and 45,374 shares, respectively, were issued under the plan.
v3.24.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted The following is a calculation of basic and diluted earnings per share and weighted-average shares outstanding (in thousands, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
 2024202320242023
Net income (loss)$(200)$1,010 $(769)$1,343 
Weighted-average shares outstanding—basic44,873 43,405 44,550 43,582 
Add shares issuable from stock-based awards(1)
— 919 — 997 
Weighted-average shares outstanding—diluted44,873 44,324 44,550 44,579 
Basic earnings (loss) per share$— $0.02 $(0.02)$0.03 
Diluted earnings (loss) per share$— $0.02 $(0.02)$0.03 
Dilutive shares issuable from unvested equity awards(1)
— 919 — 997 
Anti-dilutive shares issuable from unvested equity awards(2)
3,271 1,961 3,325 2,217 
(1) During each of the three and nine months ended September 30, 2024, 0.4 million shares were excluded from the computation of shares contingently issuable upon exercise as we recognized a net loss.
(2) Represents outstanding stock-based awards that were anti-dilutive and excluded from the calculation of diluted earnings per share.
v3.24.3
SIGNIFCANT ACCOUNTING POLICIES (Details)
$ in Thousands
Jan. 01, 2023
USD ($)
Accounting Policies [Abstract]  
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method $ 300
v3.24.3
Revenue Recognition - Disaggregated Revenue (Details) - Tech-Focused [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Disaggregated revenue $ 35,283 $ 37,433 $ 107,141 $ 114,591
Dice [Member]        
Disaggregation of Revenue [Line Items]        
Disaggregated revenue 13,415 12,663 39,538 36,639
ClearanceJobs [Member]        
Disaggregation of Revenue [Line Items]        
Disaggregated revenue $ 21,868 $ 24,770 $ 67,603 $ 77,952
v3.24.3
REVENUE RECOGNITION Revenue Recognition - Contract Balances (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]          
Accounts receivable, net of allowance for doubtful accounts of $758 and $647 $ 19,653   $ 19,653   $ 22,225
Deferred revenue 46,113   46,113   49,463
Deferred Revenue, Noncurrent 800   800   $ 508
Amounts included in the contract liability at the beginning of the period $ 26,882 $ 26,958 $ 45,444 $ 44,660  
v3.24.3
REVENUE RECOGNITION Revenue Recognition - Performance Obligations (Details) - Tech [Member]
$ in Thousands
Sep. 30, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Tech-focused revenue, remaining performance obligation $ 46,913
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Tech-focused revenue, remaining performance obligation $ 25,202
Tech-focused revenue, expected timing of satisfaction 3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Tech-focused revenue, remaining performance obligation $ 21,128
Tech-focused revenue, expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Tech-focused revenue, remaining performance obligation $ 422
Tech-focused revenue, expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Tech-focused revenue, remaining performance obligation $ 161
Tech-focused revenue, expected timing of satisfaction 1 year
v3.24.3
RESTRUCTURE COSTS (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 01, 2024
May 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, number of positions eliminated, period percent 7.00% 10.00%        
Restructuring costs $ 1,100   $ 1,111 $ 302 $ 1,111 $ 2,417
Severance Costs       100 $ 800 1,900
Employee Severance            
Restructuring Cost and Reserve [Line Items]            
Payments for restructuring       900   1,400
Accelerated Stock-Based Compensation            
Restructuring Cost and Reserve [Line Items]            
Payments for restructuring       $ 200   $ 500
v3.24.3
LEASES (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use-assets (as reported) $ 6,810,000   $ 6,810,000   $ 4,759,000
Operating lease liability 11,027,000   11,027,000   $ 8,549,000
Operating lease, impairment loss $ 0 $ 0 $ 0 $ 0  
Minimum          
Lessee, Lease, Description [Line Items]          
Lease term of contract (in years) 1 year   1 year    
Maximum          
Lessee, Lease, Description [Line Items]          
Lease term of contract (in years) 10 years   10 years    
v3.24.3
LEASES (Lease Cost) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Leases [Abstract]        
Operating lease cost(1) $ 419 $ 352 $ 1,255 $ 1,530
Sublease income (20) (25) (50) (324)
Total lease cost $ 399 $ 327 1,205 1,206
Cash paid for amounts included in measurement of lease liabilities:        
Operating cash flows from operating leases     1,110 1,832
Right-of-use assets obtained in exchange for lease obligations:        
Operating leases     $ 2,930 $ 0
v3.24.3
LEASES (Supplemental Balance Sheet Information) (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease right-of-use-assets (as reported) $ 6,810 $ 4,759
Operating lease liabilities - current 1,857 2,006
Operating lease liabilities - non-current (as reported) 9,170 6,543
Total operating lease liabilities $ 11,027 $ 8,549
Weighted Average Remaining Lease Term (in years)    
Operating leases 7 years 7 months 6 days 6 years 2 months 12 days
Weighted Average Discount Rate    
Operating leases 5.50% 4.50%
v3.24.3
LEASES (Maturities of Lease Liabilities) (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Operating Lease, After Adoption of 842    
Oct 1, 2024 through December 31, 2024 $ 554  
2025 2,206  
2026 2,211  
2027 1,331  
2028 1,276  
2029 and thereafter 6,156  
Lessee, Operating Lease, Liability, Payments, Due 13,734  
Less: imputed interest (2,707)  
Total $ 11,027 $ 8,549
v3.24.3
INVESTMENTS (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Segment Reporting Information [Line Items]                  
Equity Method Investment, Underlying Equity in Net Assets                 $ 2,200,000
Proceeds from Sale of Equity Method Investments       $ 0 $ 4,941,000        
Interest in Diluted Shares of Cost Method Investment             4.90%    
Investments, Fair Value Disclosure               $ 3,000,000  
Investment Interest Rate 7.30%     7.30%          
Equity Method Investments, Fair Value Disclosure                 $ 3,600,000
Impairment on investment   $ 400,000 $ 300,000 $ 400,000 300,000 $ 2,300,000      
Debt and Equity Securities, Unrealized Gain (Loss) $ 0   614,000 0 614,000        
Income from equity method investments       $ 325,000 428,000        
Investment ownership percentage (less than) 0.10%     0.10%          
Investment Owned, at Fair Value $ 0 0 400,000 $ 0 400,000 $ 700,000      
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount (23,000)   (153,000) (325,000) (428,000)        
Debt and Equity Securities, Unrealized Gain (Loss) 0   614,000 0 614,000        
eFinancial Careers                  
Segment Reporting Information [Line Items]                  
Equity method investment, difference between carrying amount and underlying equity     300,000   300,000        
Income from equity method investments $ 0   $ 200,000 $ 300,000 $ 400,000        
eFinancial Careers                  
Segment Reporting Information [Line Items]                  
Proceeds from Sale of Equity Method Investments   4,900,000              
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners, Common Stock Interest     10.00%   10.00%       40.00%
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)   200,000              
Debt and Equity Securities, Unrealized Gain (Loss)   600,000              
Debt and Equity Securities, Unrealized Gain (Loss)   $ 600,000              
v3.24.3
ACQUIRED INTANGIBLE ASSETS, NET (Summary of Acquired Intangible Assets) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]          
Acquired intangible assets, net $ 23,800,000   $ 23,800,000   $ 23,800,000
Impairment of intangible assets, indefinite-lived $ 0 $ 0 $ 0 $ 0  
v3.24.3
GOODWILL (Details) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Goodwill [Line Items]      
Goodwill $ 128,100,000   $ 128,100,000
Goodwill, Impairment Loss $ 0 $ 0  
v3.24.3
INDEBTEDNESS (Details)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Jun. 30, 2022
USD ($)
Sep. 30, 2024
USD ($)
Rate
Dec. 31, 2023
USD ($)
Nov. 30, 2018
USD ($)
Debt Instrument [Line Items]          
Interest margin     2.10% 2.35%  
restricted payments under the Credit Agreement     $ 7,500    
Maximum available to be borrowed under revolving facility   $ 150,000      
Total borrowed $ 32,000   $ 32,000 $ 38,000  
Line of Credit Facility, Current Borrowing Capacity   100,000      
Debt instrument, additional spread | Rate     0.10%    
Line of Credit Facility, Commitment Fee Percentage     0.35% 0.40%  
Unamortized Debt Issuance Expense   500     $ 200
Securities Borrowed   30,000      
Line of Credit Facility, Increase (Decrease), Net   $ 50,000      
Minimum          
Debt Instrument [Line Items]          
Interest margin     2.00%    
Ratio of Indebtedness to Net Capital, Pro forma basis 1.00   1.00    
Line of Credit Facility, Commitment Fee Percentage 0.35%        
Minimum | Base Rate [Member]          
Debt Instrument [Line Items]          
Interest margin     1.00%    
Maximum          
Debt Instrument [Line Items]          
Interest margin     2.75%    
Ratio of Indebtedness to Net Capital, Pro forma basis 2.00   2.00    
Line of Credit Facility, Commitment Fee Percentage 0.50%        
Maximum | Base Rate [Member]          
Debt Instrument [Line Items]          
Interest margin     1.75%    
Borrowings [Member] | Minimum          
Debt Instrument [Line Items]          
Ratio of Indebtedness to Net Capital, Pro forma basis 1.00   1.00    
Borrowings [Member] | Maximum          
Debt Instrument [Line Items]          
Ratio of Indebtedness to Net Capital, Pro forma basis 2.50   2.50    
v3.24.3
INDEBTEDNESS (Schedule of Credit Agreement) (Details)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Rate
Dec. 31, 2023
USD ($)
Debt Instrument [Line Items]      
Revolving credit facility $ 32,000 $ 32,000  
Accumulated amortization of deferred financing costs 300 300  
Total borrowed 32,000 32,000 $ 38,000
Line of Credit Facility, Remaining Borrowing Capacity $ 58,000 $ 58,000 $ 62,000
Interest margin   2.10% 2.35%
Actual interest rates 6.97% 6.97% 7.71%
Line of Credit Facility, Commitment Fee Percentage   0.35% 0.40%
Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Gross $ 700 $ 700  
Debt instrument, additional spread | Rate   0.10%  
Maximum      
Debt Instrument [Line Items]      
Interest margin   2.75%  
Line of Credit Facility, Commitment Fee Percentage 0.50%    
Ratio of Indebtedness to Net Capital, Pro forma basis 2.00 2.00  
Maximum | Borrowings [Member]      
Debt Instrument [Line Items]      
Ratio of Indebtedness to Net Capital, Pro forma basis 2.50 2.50  
v3.24.3
EQUITY TRANSACTIONS (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Feb. 09, 2023
Feb. 01, 2022
Equity, Class of Treasury Stock [Line Items]                
Stock Repurchased During Period, Shares 0   0   0 1,661,278,000    
Stock Repurchase Program, Not Settled 0   0   0 0    
Average purchase price per share (in dollars per share)         $ 0 $ 4.17    
Payments for Repurchase of Common Stock, Gross         $ 0 $ 6,928    
Stock Repurchase Program, Authorized Amount             $ 10,000 $ 15,000
2022                
Equity, Class of Treasury Stock [Line Items]                
Stock Repurchased During Period, Shares       2,600,000        
Treasury Stock, Value       $ 14,700        
2023                
Equity, Class of Treasury Stock [Line Items]                
Stock Repurchased During Period, Shares   1,400,000            
Treasury Stock, Value   $ 5,200            
v3.24.3
EQUITY TRANSACTIONS - Cash Proceeds Received and Tax Benefit from Share-based Payment Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Average purchase price per share (in dollars per share)     $ 0 $ 4.17
Restricted Stock And Performance-Based Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares repurchased upon RSU/PSU vesting (in shares) 71,076 218,432 736,144 1,143,583
Average purchase price per share (in dollars per share) $ 2.17 $ 3.76 $ 2.46 $ 5.43
Dollar value of shares repurchased upon restricted stock/PSU vesting (in thousands) $ 154 $ 821 $ 1,808 $ 6,211
v3.24.3
STOCK BASED COMPENSATION (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock based compensation expense $ 1,800 $ 2,200 $ 6,100 $ 7,700        
Unrecognized compensation expense $ 9,600   $ 9,600          
Nonvested award, cost not yet recognized, period for recognition     10 months 24 days          
Common stock, shares authorized 240,000,000   240,000,000     240,000,000    
Stock issued during period, shares, employee stock purchase plans (in shares)     81,874 45,374        
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent     85.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee     500,000          
Common stock, shares authorized 240,000,000   240,000,000     240,000,000    
Restricted Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Non-vested (in shares) 2,837,232 2,232,772 2,837,232 2,232,772 2,982,437 2,333,436 2,574,925 2,639,286
Restricted Stock | Board Member                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period     1 year          
Restricted Stock | Employee                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period     3 years          
Performance Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period     3 years          
Performance period     1 year          
Non-vested (in shares) 1,513,778 1,488,094 1,513,778 1,488,094 1,544,346 1,616,962 2,045,427 2,086,932
Performance Stock Units | Share-Based Payment Arrangement, Tranche One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting rights, percentage     33.00%          
Performance Stock Units | Share-Based Payment Arrangement, Tranche Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting rights, percentage     33.00%          
Performance Stock Units | Share-Based Payment Arrangement, Tranche Three                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting rights, percentage     33.00%          
2022                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock, shares authorized 2,900,000   2,900,000          
Common stock, shares authorized 2,900,000   2,900,000          
Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock Issued During Period, Value, Employee Stock Purchase Plan     $ 25          
Stock Issued During Period, Value, Employee Stock Purchase Plan     $ 25          
v3.24.3
STOCK BASED COMPENSATION (Status of Restricted Stock) (Details) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restricted Stock        
Shares        
Non-vested at beginning of period (in shares) 2,982,437 2,574,925 2,333,436 2,639,286
Granted (in shares) 196,000 307,174 1,857,739 1,590,172
Forfeited (in shares) 121,509 289,002 176,511 475,681
Vested (in shares) 219,696 360,325 1,177,432 1,521,005
Non-vested at end of period (in shares) 2,837,232 2,232,772 2,837,232 2,232,772
Weighted- Average Fair Value at Grant Date        
Non-vested at beginning of the period (in usd per share) $ 3.52 $ 4.82 $ 4.55 $ 3.96
Granted (in usd per share) 2.11 3.57 2.49 5.17
Forfeited (in usd per share) 3.88 5.45 3.83 5.24
Vested (in usd per share) 4.01 4.09 4.25 3.76
Non-vested at end of period (in usd per share) $ 3.37 $ 4.69 $ 3.37 $ 4.69
Performance Stock Units        
Shares        
Non-vested at beginning of period (in shares) 1,544,346 2,045,427 1,616,962 2,086,932
Granted (in shares) 0 55,128 960,000 1,412,715
Forfeited (in shares) 30,568 429,685 283,782 592,703
Vested (in shares) 0 182,776 779,402 1,418,850
Non-vested at end of period (in shares) 1,513,778 1,488,094 1,513,778 1,488,094
Weighted- Average Fair Value at Grant Date        
Non-vested at beginning of the period (in usd per share) $ 3.50 $ 4.78 $ 4.52 $ 3.48
Granted (in usd per share) 0 3.56 2.54 5.54
Forfeited (in usd per share) 3.52 5.28 4.80 5.14
Vested (in usd per share) 0 3.77 3.99 3.54
Non-vested at end of period (in usd per share) $ 3.50 $ 4.71 $ 3.50 $ 4.71
Performance Stock Units | 2022        
Shares        
Granted (in shares)       587,587
v3.24.3
STOCK BASED COMPENSATION Status of PSUs (Details) - Performance Stock Units - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Shares        
Non-vested at beginning of period (in shares) 1,544,346 2,045,427 1,616,962 2,086,932
Granted (in shares) 0 55,128 960,000 1,412,715
Forfeited (in shares) (30,568) (429,685) (283,782) (592,703)
Vested (in shares) 0 (182,776) (779,402) (1,418,850)
Non-vested at end of period (in shares) 1,513,778 1,488,094 1,513,778 1,488,094
Weighted- Average Fair Value at Grant Date        
Non-vested at beginning of the period (in usd per share) $ 3.50 $ 4.78 $ 4.52 $ 3.48
Forfeited (in usd per share) 3.52 5.28 4.80 5.14
Granted (in usd per share) 0 3.56 2.54 5.54
Vested (in usd per share) 0 3.77 3.99 3.54
Non-vested at end of period (in usd per share) $ 3.50 $ 4.71 $ 3.50 $ 4.71
2022        
Shares        
Granted (in shares)       587,587
2023        
Shares        
Forfeited (in shares)     (230,291)  
v3.24.3
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Income from continuing operations- basic and diluted $ (200) $ 1,010 $ (769) $ 1,343
Weighted average shares outstanding-basic 44,873,000 43,405,000 44,550,000 43,582,000
Weighted Average Number Diluted Shares Outstanding Adjustment 0 919,000 0 997,000
Options to purchase shares 3,271,000 1,961,000 3,325,000 2,217,000
Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares     400,000  
Weighted average diluted shares outstanding 44,873,000 44,324,000 44,550,000 44,579,000
Basic earnings (loss) per share (in dollars per share) $ 0 $ 0.02 $ (0.02) $ 0.03
Diluted earnings (loss) per share (in dollars per share) $ 0 $ 0.02 $ (0.02) $ 0.03
v3.24.3
INCOME TAXES (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
INCOME TAXES [Abstract]        
Effective Income Tax Rate Reconciliation, Percent (91.00%) 43.00% 139.00% (47.00%)
Effective income tax rate reconciliation, tax expense, share-based compensation awards     $ 400  
Effective income tax rate reconciliation, state and local income taxes     200  
Deferred Tax Assets, Tax Credit Carryforwards   $ 400   $ 400
Executive Compensation   100   $ 100
Share-based Payment Arrangement, Expense, Tax Benefit $ 100   $ 2,000  
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount   $ 100